SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma

Zhu Andrew X.; Rosmorduc Olivier; Evans T. R. Jeffry; Ross Paul J.; Santoro Armando; Carrilho Flair Jose; Bruix Jordi; Qin Shukui; Thuluvath Paul J.; Llovet Josep M.; Leberre Marie-Aude; Jensen Markus; Meinhardt Gerold; Kang Yoon-Koo

首页> 外文期刊>Journal of Clinical Oncology >SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma

【24h】

SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma

机译：搜索：晚期肝细胞癌患者中索拉非尼加厄洛替尼的III期，随机，双盲，安慰剂对照试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2015年第6期|共8页
作者
Zhu Andrew X.; Rosmorduc Olivier; Evans T. R. Jeffry; Ross Paul J.; Santoro Armando; Carrilho Flair Jose; Bruix Jordi; Qin Shukui; Thuluvath Paul J.; Llovet Josep M.; Leberre Marie-Aude; Jensen Markus; Meinhardt Gerold; Kang Yoon-Koo;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma [J] . Zhu Andrew X., Rosmorduc Olivier, Evans T. R. Jeffry, Journal of Clinical Oncology . 2015,第6期

机译：搜索：晚期肝细胞癌患者中索拉非尼加厄洛替尼的III期，随机，双盲，安慰剂对照试验
2. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased alpha-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial [J] . Zhu Andrew X., Kang Yoon-Koo, Yen Chia-Jui, The lancet oncology . 2019,第2期

机译：RAMUCIRUMAB在肝细胞癌晚期患者中的索拉非尼蛋白和α-胎蛋白浓度增加（REACH-2）：随机，双盲，安慰剂控制，第3期试验
3. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased alpha-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial [J] . Zhu Andrew X., Kang Yoon-Koo, Yen Chia-Jui, Nature reviews neuroscience . 2019,第2期

机译：RAMUCIRUMAB在肝细胞癌晚期患者中的索拉非尼蛋白和α-胎蛋白浓度增加（REACH-2）：随机，双盲，安慰剂控制，第3期试验
4. Molecular Therapies in Hepatocellular Carcinoma beyond Sorafenib: Lessons from Failed Phase III Trials and Novel Targets [C] . Lipika Goyal, Andrew X. Zhu Gastrointestinal Cancers Symposium . 2014

机译：Sorafenib之外的肝细胞癌中的分子疗法：III期试验失败的课程和新型靶标
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. P-285A randomized double-blind placebo-controlled Phase III study of ramucirumab versus placebo as second-line treatment in patients with hepatocellular carcinoma and elevated baseline alpha-fetoprotein following first-line sorafenib (REACH-2) [O] . Zhu Andrew, Galle Peter, Kudo Masatoshi, -1

机译：P-285A雷莫昔单抗和安慰剂作为肝细胞癌和一线索拉非尼（REACH-2）基线甲胎蛋白升高的患者的二线治疗的随机双盲安慰剂对照III期研究
7. Search: A phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma [O] . Zhu Andrew X., Rosmorduc Olivier, Evans T.R. Jeffry, 2017

机译：搜索：索拉非尼联合厄洛替尼治疗晚期肝细胞癌的一项随机，双盲，安慰剂对照III期临床试验

SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅